Invasive fungal disease was common (14%) after steroid therapy for severe graft-versus-host disease
Viral disease was common (∼25%) after steroid therapy for severe graft-versus-host disease
Gram-negative rod infection was common (20%) after steroid therapy for severe graft-versus-host disease
Graft-versus-host disease within 26 days and low lymphocyte count correlated with risk of infection
Cumulative steroid doses correlated with risks of fungal and viral diseases